Digital Media Center
Bryant-Denny Stadium, Gate 61
920 Paul Bryant Drive
Tuscaloosa, AL 35487-0370
(800) 654-4262

© 2024 Alabama Public Radio
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Register for Glenn Miller Tickets in Mobile on May 30.

Pfizer Asks FDA To Approve Its COVID-19 Vaccine For Emergency Use

The pharmaceutical giant Pfizer is formally requesting federal approval for emergency use of the company's COVID-19 vaccine
Justin Tallis
/
AFP via Getty Images
The pharmaceutical giant Pfizer is formally requesting federal approval for emergency use of the company's COVID-19 vaccine

Pfizer is formally asking federal authorities to authorize its COVID-19 vaccine for emergency use. The pharmaceutical giant and its partner BioNTech announced that they are submitting their request to the Food and Drug Administration on Friday.

"Filing for Emergency Use Authorization in the U.S. is a critical step in making our vaccine candidate available to the global population as quickly as possible," BioNTech CEO Ugur Sahin said in a joint statement released by the companies. "We intend to continue to work with regulatory agencies worldwide to enable the rapid distribution of our vaccine globally."

The request comes as little surprise, as NPR's Joe Palca reported Thursday that the companies intended to move quickly after the release of promising clinical trial data about the vaccine earlier this week. The final analysis of the vaccine, released Wednesday, found the vaccine to be 95% effective — a significant improvement over the 90% effectiveness shown in an interim analysis earlier this month.

On Thursday, Pfizer CEO Albert Bourla told NPR's All Things Considered that once the vaccine receives federal authorization for emergency use, "we will be ready to start distributing our vaccine within hours."

The vaccine developed by Pfizer and BioNTech is not alone. The American biotech company Moderna announced Monday that its own COVID-19 vaccine is 94.5% effective in preventing illness following exposure to the coronavirus.

Moderna is also expected to file a request with the FDA to begin emergency use.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Colin Dwyer covers breaking news for NPR. He reports on a wide array of subjects — from politics in Latin America and the Middle East, to the latest developments in sports and scientific research.
News from Alabama Public Radio is a public service in association with the University of Alabama. We depend on your help to keep our programming on the air and online. Please consider supporting the news you rely on with a donation today. Every contribution, no matter the size, propels our vital coverage. Thank you.